FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

• Application Integrity Policy:

• Compliance Lists:
  
  FDA Debarment List - Firms or persons convicted of a felony under Federal law for conduct relating to the development or approval, including the process for development or approval, of any new or abbreviated drug application.
  
  Disqualified/Restricted/Assurance List for Clinical Investigators
  
  Nonclinical Laboratories Inspected under GLP Regulations since FY 1990
  
  Public Health Service Administrative Actions Listing (Link to external document, not maintained by FDA/ORA)
  

• Compliance Policy Guides - Bimo Related:

  100.900	International Memoranda of Understanding  (June, 1995) Link to FDA International Program WebSite
  120.100	Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities (CPG 7150.09) (July, 1991)
  130.300	FDA Access to Results of Quality Assurance Program Audits and Inspections (CPG 7151.02) (Jan. 1996)

• Compliance Programs:

  In Vivo Bioequivalence	7348.001 (HTML)	78 KB
  Good Laboratory Practice (Non-Clinical Laboratories)	7348.808 (HTML)	3.3 MB
  Good Laboratory Practice (EPA Data Audit Inspections)	7348.808A (HTML)	31 KB
  Institutional Review Boards (IRB)	7348.809 (HTML Not Available (N/A))	1.05 MB
  Sponsors, Contract Research Organizations and Monitors	7348.810 (HTML)	1.8 MB
  Clinical Investigators (CI)	7348.811 (HTML)	3.24 MB

• Guidance for Industry:

  Good Laboratory Practice Regulations Management Briefings Post Conference Report	Aug. 1979 (HTML)	n/a
  GLP Questions and Answers	HTML	52 KB
  Computerized Systems Used In Clinical Trials	Apr. 1999 (HTML)	46 KB
  Guideline for the Monitoring of Clinical Investigations	Jan. 1988 (HTML)	PDF,16kb
  Draft Guidance: Exception from Informed Consent-Emergency Research	July 2006	2.86 MB

• FDA Regulations - Title 21 Code of Federal Regulations:

  Part 50--PROTECTION OF HUMAN SUBJECTS	(HTML)
  Part 56--INSTITUTIONAL REVIEW BOARDS	(HTML)
  Part 58--GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES	(HTML)
  Part 312--INVESTIGATIONAL NEW DRUG APPLICATION	(HTML)
  Part 320--BIOAVAILABILITY AND BIOEQUIVALENCE REQUIREMENTS	(HTML)
  Part 511--NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE	(HTML)
  Part 812--INVESTIGATIONAL DEVICE EXEMPTIONS	(HTML)

• Good Laboratory Practice (GLP) Resources:

  
  

Comparison Chart of FDA, Environmental Protection Agency (EPA), and Organization for Economic Co-operation and Development (OECD)	HTML	1.79 mb
Good Laboratory Practice (GLP), Proposed Rule, 11/19/1976	HTML N/A	6170 KB
Good Laboratory Practice (GLP) Final Rule, 12/22/1978	HTML N/A	8355 KB
Good Laboratory Practice (GLP), Proposed Rule, 10/29/1984	HTML N/A	1762 KB
Good Laboratory Practice (GLP), Amendment, Final Rule, 9/4/1987	HTML N/A	3167 KB
OECD GLP Internet (Organization for Economic Co-operation and Development) (Link to an external site, not part of the FDA web)

About ORA | Site Map/Index | ORA Search
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

Office of Regulatory Affairs